Simulations Plus (NASDAQ:SLP) Receives Outperform Rating from William Blair

William Blair reissued their outperform rating on shares of Simulations Plus (NASDAQ:SLP) in a research report report published on Wednesday,RTT News reports. William Blair also issued estimates for Simulations Plus’ Q2 2025 earnings at $0.22 EPS, Q3 2025 earnings at $0.34 EPS, Q4 2025 earnings at $0.35 EPS, FY2025 earnings at $1.09 EPS, Q1 2026 earnings at $0.17 EPS, Q2 2026 earnings at $0.32 EPS, Q3 2026 earnings at $0.44 EPS, Q4 2026 earnings at $0.43 EPS and FY2026 earnings at $1.35 EPS.

A number of other equities research analysts also recently commented on SLP. Stephens assumed coverage on shares of Simulations Plus in a research report on Friday, November 15th. They issued an “overweight” rating and a $39.00 price objective on the stock. StockNews.com downgraded Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, November 4th. Finally, BTIG Research dropped their price objective on Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a report on Thursday, October 24th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Simulations Plus currently has a consensus rating of “Moderate Buy” and a consensus price target of $49.00.

Simulations Plus Stock Performance

NASDAQ SLP opened at $28.25 on Wednesday. Simulations Plus has a one year low of $24.00 and a one year high of $51.22. The firm has a market cap of $567.40 million, a price-to-earnings ratio of 57.65 and a beta of 0.80. The firm has a 50 day simple moving average of $29.82 and a 200-day simple moving average of $33.82.

Simulations Plus (NASDAQ:SLP) last released its earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The firm had revenue of $18.70 million during the quarter, compared to analyst estimates of $19.73 million. During the same period last year, the business posted $0.18 earnings per share. Simulations Plus’s revenue was up 19.9% compared to the same quarter last year. Equities analysts predict that Simulations Plus will post 1.1 EPS for the current fiscal year.

Insider Buying and Selling

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $31.76, for a total transaction of $635,200.00. Following the transaction, the director now directly owns 3,442,584 shares in the company, valued at approximately $109,336,467.84. This represents a 0.58 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 19.40% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Arizona State Retirement System acquired a new stake in shares of Simulations Plus during the second quarter valued at $218,000. Los Angeles Capital Management LLC acquired a new stake in shares of Simulations Plus during the 2nd quarter worth about $206,000. Wedbush Securities Inc. grew its holdings in shares of Simulations Plus by 10.5% during the second quarter. Wedbush Securities Inc. now owns 18,025 shares of the technology company’s stock worth $876,000 after buying an additional 1,709 shares in the last quarter. Envestnet Asset Management Inc. raised its position in shares of Simulations Plus by 1.5% in the second quarter. Envestnet Asset Management Inc. now owns 54,813 shares of the technology company’s stock valued at $2,665,000 after buying an additional 784 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Simulations Plus by 10.1% during the second quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock valued at $20,128,000 after buying an additional 37,992 shares during the period. Hedge funds and other institutional investors own 78.08% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.